1036 related articles for article (PubMed ID: 12137559)
1. Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?
Evans M; Rees A
Drug Saf; 2002; 25(9):649-63. PubMed ID: 12137559
[TBL] [Abstract][Full Text] [Related]
2. Statins and myotoxicity: a therapeutic limitation.
Tiwari A; Bansal V; Chugh A; Mookhtiar K
Expert Opin Drug Saf; 2006 Sep; 5(5):651-66. PubMed ID: 16907655
[TBL] [Abstract][Full Text] [Related]
3. HMG-CoA reductase inhibitors and myotoxicity.
Ucar M; Mjörndal T; Dahlqvist R
Drug Saf; 2000 Jun; 22(6):441-57. PubMed ID: 10877038
[TBL] [Abstract][Full Text] [Related]
4. The myotoxicity of statins.
Evans M; Rees A
Curr Opin Lipidol; 2002 Aug; 13(4):415-20. PubMed ID: 12151857
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.
Williams D; Feely J
Clin Pharmacokinet; 2002; 41(5):343-70. PubMed ID: 12036392
[TBL] [Abstract][Full Text] [Related]
6. Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors.
Jamal SM; Eisenberg MJ; Christopoulos S
Am Heart J; 2004 Jun; 147(6):956-65. PubMed ID: 15199341
[TBL] [Abstract][Full Text] [Related]
7. Rhabdomyolysis and statin therapy: relevance to the elderly.
Sica DA; Gehr TW
Am J Geriatr Cardiol; 2002; 11(1):48-55. PubMed ID: 11773716
[TBL] [Abstract][Full Text] [Related]
8. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
Chang JT; Staffa JA; Parks M; Green L
Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
[TBL] [Abstract][Full Text] [Related]
9. Statin-associated myopathy.
Thompson PD; Clarkson P; Karas RH
JAMA; 2003 Apr; 289(13):1681-90. PubMed ID: 12672737
[TBL] [Abstract][Full Text] [Related]
10. [Safety profile of statins].
Prieto JC
Rev Med Chil; 2001 Nov; 129(11):1237-40. PubMed ID: 11836874
[TBL] [Abstract][Full Text] [Related]
11. Statin-fibrate combination therapy.
Shek A; Ferrill MJ
Ann Pharmacother; 2001; 35(7-8):908-17. PubMed ID: 11485144
[TBL] [Abstract][Full Text] [Related]
12. Safety considerations for statins.
Bolego C; Baetta R; Bellosta S; Corsini A; Paoletti R
Curr Opin Lipidol; 2002 Dec; 13(6):637-44. PubMed ID: 12441888
[TBL] [Abstract][Full Text] [Related]
13. Statin-induced myotoxicity: pharmacokinetic differences among statins and the risk of rhabdomyolysis, with particular reference to pitavastatin.
Catapano AL
Curr Vasc Pharmacol; 2012 Mar; 10(2):257-67. PubMed ID: 22022768
[TBL] [Abstract][Full Text] [Related]
14. Statins and myotoxicity.
Farmer JA
Curr Atheroscler Rep; 2003 Mar; 5(2):96-100. PubMed ID: 12573193
[TBL] [Abstract][Full Text] [Related]
15. Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin.
Jones PH; Davidson MH
Am J Cardiol; 2005 Jan; 95(1):120-2. PubMed ID: 15619408
[TBL] [Abstract][Full Text] [Related]
16. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and rhabdomyolysis: considerations in the renal failure patient.
Sica DA; Gehr TW
Curr Opin Nephrol Hypertens; 2002 Mar; 11(2):123-33. PubMed ID: 11856903
[TBL] [Abstract][Full Text] [Related]
17. Rhabdomyolysis and HMG-CoA reductase inhibitors.
Omar MA; Wilson JP; Cox TS
Ann Pharmacother; 2001 Sep; 35(9):1096-107. PubMed ID: 11573861
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of a squalene synthase inhibitor, lapaquistat acetate (TAK-475), on statin-induced myotoxicity in guinea pigs.
Nishimoto T; Ishikawa E; Anayama H; Hamajyo H; Nagai H; Hirakata M; Tozawa R
Toxicol Appl Pharmacol; 2007 Aug; 223(1):39-45. PubMed ID: 17599378
[TBL] [Abstract][Full Text] [Related]
19. Statin safety and drug interactions: clinical implications.
Bottorff MB
Am J Cardiol; 2006 Apr; 97(8A):27C-31C. PubMed ID: 16581325
[TBL] [Abstract][Full Text] [Related]
20. Skeletal muscle-specific HMG-CoA reductase knockout mice exhibit rhabdomyolysis: A model for statin-induced myopathy.
Osaki Y; Nakagawa Y; Miyahara S; Iwasaki H; Ishii A; Matsuzaka T; Kobayashi K; Yatoh S; Takahashi A; Yahagi N; Suzuki H; Sone H; Ohashi K; Ishibashi S; Yamada N; Shimano H
Biochem Biophys Res Commun; 2015 Oct; 466(3):536-40. PubMed ID: 26381177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
